These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21890811)

  • 1. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
    de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
    Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Fijneman RJ; Meijer GA
    J Pathol; 2012 Feb; 226(3):442-50. PubMed ID: 22009326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
    Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
    Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue and serum galectin-1 expression in patients with colorectal carcinoma.
    Sheng TH; Rong LX; Li ZY; Bo J; Lei S
    Hepatogastroenterology; 2012; 59(114):389-94. PubMed ID: 22353504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma.
    Melle C; Ernst G; Schimmel B; Bleul A; Mothes H; Kaufmann R; Settmacher U; Von Eggeling F
    Int J Oncol; 2006 Jan; 28(1):195-200. PubMed ID: 16327996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
    Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
    J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
    Kodach LL; Bleuming SA; Musler AR; Peppelenbosch MP; Hommes DW; van den Brink GR; van Noesel CJ; Offerhaus GJ; Hardwick JC
    Cancer; 2008 Jan; 112(2):300-6. PubMed ID: 18008360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
    Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
    Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma.
    Zhao L; Wang H; Sun X; Ding Y
    FEBS J; 2010 Oct; 277(20):4195-204. PubMed ID: 20812987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
    Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
    Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc finger protein OZF (ZNF146) is overexpressed in colorectal cancer.
    Ferbus D; Bovin C; Validire P; Goubin G
    J Pathol; 2003 Jun; 200(2):177-82. PubMed ID: 12754738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening.
    Kahi CJ; Anderson JC; Waxman I; Kessler WR; Imperiale TF; Li X; Rex DK
    Am J Gastroenterol; 2010 Jun; 105(6):1301-7. PubMed ID: 20179689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.